Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Buy
55
TRVI Quote, Financials, Valuation and Earnings
Last price:
$6.58
Seasonality move
:
7.34%
Day range:
$5.38 - $6.24
52-week range:
$2.30 - $7.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
6.09x
Volume:
4.5M
Avg. volume:
1.6M
1-year change:
133.33%
Market cap:
$605.4M
Revenue:
--
EPS (TTM):
-$0.45
Trevi Therapeutics Number of Institutional Trades
Trevi Therapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$703.2M
(Last 6 Months)
Current Institutional Ownership Percentage
97.01%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$455.9M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Trevi Therapeutics Institutional Ownership
-
What Percentage Of TRVI Is Owned by Institutions?
97.01% of TRVI is owned by institutions.
-
How Many Institutions Own TRVI Shares?
Trevi Therapeutics stock is owned by 234 institutional shareholders at this time.
-
Have Institutions Been Buying TRVI Stock?
Yes, institutions have bought 90.9M shares of TRVI in the last quarter.
-
Have Institutions Been Selling TRVI Stock?
Yes, institutions have sold 57.5M shares of TRVI over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
